The New York Times, the FDA intends to authorize use of the vaccine on Friday. The FDA said there were "no specific safety concerns identified that would preclude issuance of an EUA (emergency use authorisation)" and confirmed an overall efficacy of 94.1 percent.The upbeat assessment came a day after a mass vaccination drive in the United States, the world's worst-affected country.